Development of stem cell-based therapy for Parkinson's disease
Fabin Han1, Deborah Baremberg1, Junyu Gao1
1Centre for Stem Cells and Regenerative Medicine, The Liaocheng People's Hospital/Affiliated Liaocheng Hospital, Taishan Medical University, Shandong, 252000 China.
Translational Neurodegeneration
|September 5, 2015
Summary
Cell therapies offer new hope for Parkinson's disease (PD) treatment by replacing lost dopamine neurons. Induced pluripotent stem cells (iPSCs) show promise for large-scale clinical applications in PD therapy.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Stem Cell Biology
Background:
- Parkinson's disease (PD) is a common neurodegenerative disorder characterized by dopamine neuron loss.
- Current treatments manage symptoms but do not halt disease progression.
- Cell therapy presents a promising avenue for Parkinson's disease treatment.
Purpose of the Study:
- To evaluate research progress in various cell sources for Parkinson's disease therapy.
- To focus on induced pluripotent stem cells (iPSCs) as a key cell source.
- To identify challenges for clinical application of cell-based Parkinson's treatments.
Main Methods:
- Review of current research on different cell sources for PD.
- Evaluation of induced pluripotent stem cells (iPSCs) for dopamine neuron replacement.
- Analysis of challenges for large-scale clinical translation of cell therapies.
Main Results:
- Multiple cell sources, including neural stem cells (NSCs), embryonic stem cells (hESCs), iPSCs, and directly induced dopamine neurons (iDA neurons), are being investigated.
- Induced pluripotent stem cells (iPSCs) are highlighted as a valuable source for potential PD treatments.
- Key challenges for clinical application of cell therapies in PD were identified.
Conclusions:
- Cell therapies, particularly those utilizing iPSCs, hold significant potential for treating Parkinson's disease.
- Addressing challenges in cell source development is crucial for successful large-scale clinical application.
- Further research is needed to optimize cell-based strategies for halting PD progression.
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:22iPS Cell Differentiation
3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
01:15Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
01:13Induced Pluripotent Stem Cells
28.6K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.6K
01:06Induced Pluripotent Stem Cells
6.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
6.3K